Standardizing Immunohistochemistry: A New Reference Control for Detecting Staining Problems

Seshi R Sompuram1, Kodela Vani1, Brian Tracey2

  • 1Medical Discovery Partners LLC, Boston, Massachusetts (SRS,KV,SAB)

Insights

A novel immunohistochemistry (IHC) control using peptide-coated beads offers standardized breast cancer testing. These "IHControls" ensure reliable detection of human epidermal growth factor receptor 2, estrogen receptor, and progesterone receptor, enhancing diagnostic accuracy.

Area of Science:

  • Biotechnology
  • Cancer Diagnostics
  • Immunohistochemistry

Background:

  • Standardized immunohistochemistry (IHC) controls are crucial for accurate breast cancer testing.
  • Current tissue-based controls can present challenges in reproducibility and standardization across laboratories.
  • Need for a robust control system to validate the analytical performance of IHC assays.

Purpose of the Study:

  • To introduce and evaluate a new standardized IHC control system, termed "IHControls", for breast cancer biomarker testing.
  • To assess the sensitivity and specificity of IHControls in detecting common issues in IHC staining procedures.
  • To compare the performance of IHControls against traditional tissue-based controls.

Main Methods:

  • Development of IHControls using formalin-fixed peptide antigens (HER2, ER, PR) covalently attached to glass beads.
  • Suspension of antigen-coated beads in a liquid matrix that solidifies on a microscope slide.
  • Testing IHControls by simulating various staining problems, including reagent degradation and suboptimal antigen retrieval conditions (time, temperature).

Main Results:

  • IHControls demonstrated sensitivity in detecting primary and secondary reagent degradation, comparable to tissue controls.
  • The controls effectively identified aberrations in antigen retrieval, mirroring the performance of tissue controls.
  • Specificity testing confirmed that each bead reacted only with its corresponding IHC antibody, validating assay specificity.

Conclusions:

  • IHControls are capable of verifying the analytical components of immunohistochemical staining, similar to tissue controls.
  • The bead-based format allows for bulk preparation, promoting day-to-day reproducibility and inter-laboratory standardization.
  • IHControls represent a promising advancement for standardized and reliable breast cancer biomarker assessment.